Pezzilli Raffaele, Morselli-Labate Antonio Maria, Casadei Riccardo, Campana Davide, Rega Daniela, Santini Donatella, Calculli Lucia, Corinaldesi Roberto
Department of Digestive Diseases and Internal Medicine, Sant'Orsola-Malpighi Hospital, Via Massarenti 9, Bologna, Italy.
Scand J Gastroenterol. 2009;44(7):888-93. doi: 10.1080/00365520902839683.
Prospectively to evaluate patients with chronic asymptomatic pancreatic hyperenzymemia in order to identify possible pancreatic and non-pancreatic diseases.
Seventy-five asymptomatic subjects with long-standing pancreatic hyperenzymemia (45 M, 30 F; mean age+/-SD 51.5+/-16.0 years, range 19-78 years, mean duration+/-SD of pancreatic hyperenzymemia 14.7+/-7.0 months, range 7-34 months) and normal ultrasonographic evaluation were included in this study. The subjects enrolled were carefully interviewed and prospectively evaluated. All patients underwent blood screening. An additional abdominal ultrasound was also carried out and, if considered necessary, other imaging and endoscopic evaluation procedures were used.
The follow-up of the patients after enrollment in the study was 3.3+/-1.8 years (mean+/-SD). In 38 patients (50.7%), pancreatic or extrapancreatic disease was diagnosed: 20 patients had chronic pancreatitis, 1 had autoimmune chronic pancreatitis, 1 had a benign cyst of the pancreas, 2 had serous cystadenomas, 5 had an intraductal papillary mucinous tumor of the pancreas, 3 had a ductal pancreatic adenocarcinoma, 4 patients had chronic viral hepatitis, and 2 had Crohn's disease. In 37 subjects (49.3%), no pancreatic or extrapancreatic diseases were found (3 subjects had macroamylasemia, 3 had familial hyperenzymemia, 31 had chronic non-pathological pancreatic hyperenzymemia).
Subjects having an increase of either amylase or lipase serum levels should undergo a thorough diagnostic work-up prior to establishing the existence of chronic non-pathological pancreatic hyperenzymemia.
对慢性无症状性胰腺酶血症患者进行前瞻性评估,以确定可能的胰腺和非胰腺疾病。
本研究纳入了75例长期存在胰腺酶血症的无症状受试者(45例男性,30例女性;平均年龄±标准差51.5±16.0岁,范围19 - 78岁,胰腺酶血症平均病程±标准差14.7±7.0个月,范围7 - 34个月),且超声检查结果正常。对纳入的受试者进行了仔细的访谈和前瞻性评估。所有患者均接受了血液筛查。此外,还进行了腹部超声检查,如有必要,还采用了其他影像学和内镜评估程序。
研究入组患者的随访时间为3.3±1.8年(平均±标准差)。38例患者(50.7%)被诊断出患有胰腺或胰腺外疾病:20例患有慢性胰腺炎,1例患有自身免疫性慢性胰腺炎,1例患有胰腺良性囊肿,2例患有浆液性囊腺瘤,5例患有胰腺导管内乳头状黏液性肿瘤,3例患有胰腺导管腺癌,4例患有慢性病毒性肝炎,2例患有克罗恩病。37例受试者(49.3%)未发现胰腺或胰腺外疾病(3例患有巨淀粉酶血症,3例患有家族性酶血症,31例患有慢性非病理性胰腺酶血症)。
在确定存在慢性非病理性胰腺酶血症之前,血清淀粉酶或脂肪酶水平升高的受试者应接受全面的诊断检查。